본문 바로가기
KERD
논문KCI 등재

生地黃飮子 추출물이 단핵세포에서 당화종말산물로 유도된 염증반응에 미치는 효과

Effects of Saengjihwangeum-ja Extracts on the Expression of Inflammatroy Response in Human Monocyte Cells Induced by Advanced Glycation End Product

한웅|정한솔|이광규
한의병리학회 (The Society of Pathology in Korean Medicine)|2009.12|동의생리병리학회지 (Journal of Physiology & Pathology in Korean Medicine)|제23권 제6호|pp. 1305-1313

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

AGEmaillard reaction product
주제분류한의학

초록

Saengjihwangeum-ja (SJHEJ) was recorded in DongEuiBoGam as being able to be used for treatment of Sogal whose concept had been applied to Diabetes Mellitus (DM). Modification of proteins by long term circulation of glucose leads to the formation of advanced glycation end product(AGE). Recent immunological studies demonstrated that ligation of AGE play an important role in the development of diabetic complications including atherosclerosis, which includes activation, adhesion, and migration of monocytes. Also, AGE and Maillard reaction product(MRP) could augment monocyte inflammatory responses via ligation of AGE receptor. In this study, the effects of SJHEJ extracts on the expression of inflammatory response-related genes such as tumor necrosis factor-α, monocyte chemoattractant protein-1, interferon-g-inducible protein-10, and cyclooxygenase-2 in the human monocyte cell line, THP-1 cells. Reverse transcriptase-polymerase chain reaction revealed that SJHEJ had inhibitory effects on the expression of the TNF-a, MCP-1, IP-10, COX2, IL-1b genes in MRP-induced THP-1 cells. Treatment with SJHEJ had reduced reactive oxygen production in THP-1 cells stimulated by MRP. These inhibitory effects might be exerted via prevention of oxidative stress in activated monocytes. In addition, radical scavenging activity of SJHEJ was increased. These results suggest that SJHEJ has a beneficial effects for improve diabetic vascular complication.

Abstract

Saengjihwangeum-ja (SJHEJ) was recorded in DongEuiBoGam as being able to be used for treatment of Sogal whose concept had been applied to Diabetes Mellitus (DM). Modification of proteins by long term circulation of glucose leads to the formation of advanced glycation end product(AGE). Recent immunological studies demonstrated that ligation of AGE play an important role in the development of diabetic complications including atherosclerosis, which includes activation, adhesion, and migration of monocytes. Also, AGE and Maillard reaction product(MRP) could augment monocyte inflammatory responses via ligation of AGE receptor. In this study, the effects of SJHEJ extracts on the expression of inflammatory response-related genes such as tumor necrosis factor-α, monocyte chemoattractant protein-1, interferon-g-inducible protein-10, and cyclooxygenase-2 in the human monocyte cell line, THP-1 cells. Reverse transcriptase-polymerase chain reaction revealed that SJHEJ had inhibitory effects on the expression of the TNF-a, MCP-1, IP-10, COX2, IL-1b genes in MRP-induced THP-1 cells. Treatment with SJHEJ had reduced reactive oxygen production in THP-1 cells stimulated by MRP. These inhibitory effects might be exerted via prevention of oxidative stress in activated monocytes. In addition, radical scavenging activity of SJHEJ was increased. These results suggest that SJHEJ has a beneficial effects for improve diabetic vascular complication.

참고문헌 (52)

  1. 이준영, "2005-2006년 당뇨병 기초통계연구 TFT 중간 보고 ; DisMod를 이용한 우리나라 당뇨병 유병률의 추정", 당뇨병 기초통계연구 TFT 심포지움, pp.224~226 (2006), 대한 당뇨병학회
  2. Bucala, R., "Advanced glycosylation end products in diabetic complications", Diabetes Rev, 3, pp.258~268 (1995)
  3. Bierhaus, A, "AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept", Cardiovasc Res, 37, pp.586~600 (1998)
  4. Sheetz, M.J, "Molecular understanding of hyperglycemia's adverse effects for diabetic complications", JAMA, 288, pp.2579~2588 (2002)
  5. Ahemed, N., "Advanced glycation endproduct: what is their relevance to diabetic complications?", Diabetes, Obesity and Metabolism, 9, pp.233~245 (2007)
  6. 杜鎬京, "東醫腎系學", pp.939~990 (1991), 동양의학연구원
  7. 楊思樹, "동의임상내과학", pp.396~413 (1999), 법인문화사
  8. 龔廷賢, "萬病回春", pp.70~71 (1983), 大中國圖書公私
  9. 葛芳芳, "淺析《內經》中消渴之論述", 上海中醫藥雜誌, 41, pp.60~62 (2007)
  10. 巢元方, "巢氏諸病源候論, 卷五", pp.161~, 昭人出版社
  11. 孫思邈, "備急千金要方", pp.651~ (1992), 대성문화사
  12. 黃瑛, "淺議《外科正宗》對消渴脫疽的論治", 新中醫, 37, pp.77~78 (2005)
  13. 李杲, "東垣十種醫書", pp.164~167 (1983), 대성문화사
  14. 金禮蒙, "醫方類聚", pp.344~ (1993), 醫聖堂
  15. 曹孝忠, "聖濟總錄", pp.504~520 (1994), 신문풍출판공사
  16. 劉河間, "傷寒 三六書", pp.82~83 (1976), 성보사
  17. 危亦林, "世醫得效方", pp.167~168 (1981), 도서출판 금강출판사
  18. 許浚, "東醫寶鑑·雜病篇 卷六", pp.1405~ (2007), 법인문화사
  19. Mishell, B.B., "Selected methods in cellular immunology", pp.16~ (1980), Freeman and W. M. Co.
  20. Mosmann, T., "Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxic assays", J. Immunol. Methods, 65, pp.55~63 (1983)
  21. Birch, D.E., "Simplified Hot-Start PCR", Nature, 381, pp.445~446 (1996)
  22. Blois, M.S., "Antioxidant determination by the use a stable free radicals", Nature, 26, pp.1191~1204 (1958)
  23. Diabetes Atlas, "International Diabetes Federation, 2nd ed" (2003)
  24. Ruderman, N., "Glucose and diabetic vascular disease", FASEB J, 6, pp.2905~2914 (1992)
  25. Pugliese, G., "Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease", Diabete Metab Rev, 7, pp.35~59 (1991)
  26. Brownlee, M., "Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications", N Engl J Med, 318, pp.1315~1321 (1988)
  27. Schmidt, A., "Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions", Arterioscler Thromb, 14, pp.1521~1528 (1994)
  28. American Diabetes Association, "Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes", Diabetes Care, 12, pp.573~579 (1989)
  29. Geiss, L., "Mortality in non-insulin dependent diabetes", pp.233~258 (1995), National Institutes of Health
  30. M. Brownlee, "Advanced protein glycosylation in diabetes and aging", Ann Rev Med, 46, pp.223~234 (1995)
  31. S.K. Grandhee, "Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors", J Biol Chem, 266, pp.11649~11653 (1991)
  32. Rahbar, S, "Hemoglobin H disease in two Iranian families", Clinica Chimica Acta, 20, pp.381~385 (1968)
  33. Rahbar, S., "Studies of an unusual hemoglobin in patients with diabetes mellitus", Biochemical and Biophysical Research Communications, 36, pp.838~843 (1969)
  34. Bucala, R., "Advanced glycosylation end products in diabetic complications", Diabetes Rev, 3, pp.258~268 (1995)
  35. Brownlee, M., "Biochemistry and molecular cell biology of diabetic complications", Nature, 414, pp.813~820 (2001)
  36. 대한병리학회, "병리학II. 제6판", pp.702~ (2007), Korea Seoul Komoonsa Medical Science
  37. Chappy, O., "Advanced glycation end products, oxidant stress and vascular lesions", Eur J Clin Invest, 27, pp.97~108 (1997)
  38. Horiuchi, S., "Extra- and intracellular localization of advanced glycation end-products in human atherosclerotic lesions", Nephrol Dial Transplant, 11(5), pp.81~86 (1996)
  39. H. Vlassara, "Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging", Lab Invest, 70, pp.138~151 (1994)
  40. 金達鎬, "注解補注 黃帝內經 素問(上)", pp.974~ (2001), 도서출판 의성당
  41. 葛芳芳, "淺析《內經》中消渴之論述", 上海中醫藥雜誌, 41, pp.60~62 (2007)
  42. 金達鎬, "注解補注 黃帝內經 靈樞", pp.877~ (2002), 醫聖堂
  43. 王燾, "外臺秘要, 卷十一, 消渴方一十七首", pp.339~ (1992), 대성문화사
  44. 楊士瀛, "仁齊直指, 卷十七, 消渴, 消渴方論", pp.744~ (1995), 여강출판사
  45. 許浚, "東醫寶鑑 雜病篇 卷六 消渴", pp.1408~ (2007), 법인문화사
  46. 강석봉, "소갈의 전병증과 당뇨병의 만성합병증에 대한 비교고찰", 대한한의학회지, 36, pp.137~152 (1998)
  47. Gu, L., "Monocyte chemoattractant protein-1", Chem Immunol, 72, pp.7~29 (1999)
  48. Shanmugam, N., "High glucose-induced expressioin of proinflammatory cytokine and chemokine gene in monycytic cells", Diagetes, 52, pp.1256~1264 (2003)
  49. Shimada, A., "Elevated serum IP-10 levels observed in type 1 diabetes", Diabetes Care, 24, pp.510~515 (2001)
  50. Inoue, H., "Glucocorticoid-mediated suppression of the promotor activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells", Biochem Bioph Res Commun, 254, pp.292~298 (1999)
  51. Tabatabaie, T., "Free Radicals and the Pathogenesis of Type 1 Diabetes: beta-Cell Cytokine-Mediated Free Radical Generation Via Cyclooxygenase-2", Diabetes, 52, pp.1994~1999 (2003)
  52. Miquel, J., "Handbook of free radicals and antioxidants in biomedicine 1", pp.223~ (1989), CRC Press

관련 논문AI추천

黃芩湯 추출물이 THP-1 세포에서 당화종말산물에 의한 염증반응에 미치는 효과김재은, 신상우, 이광규, 이상룡, 이창현, 정상훈, 정한솔, 하기태한의병리학회 · 동의생리병리학회지2012 · 제26권 제2호황금 물추출물의 당화종말산물로 유도한 THP-1 세포의 염증반응 억제효과김민준, 박평범, 신경호, 이광규, 이상룡, 이창현, 정한솔, 하기태한의병리학회 · 동의생리병리학회지2012 · 제26권 제3호고농도 포도당에 노출된 마우스 신장상피세포에서 桑枝의 산화 스트레스 억제 효과신현철, 장수영대한한방내과학회 · 대한한방내과학회지2011 · 제32권 제1호쇄양의 항산화 및 항염증 효과김경애, 박선동, 윤현정, 이효승한의병리학회 · 동의생리병리학회지2009 · 제23권 제6호淸營金飮이 자유산소라디칼과 염증매개인자에 미치는 영향김승태, 김형우, 우원홍, 이부균, 이영철, 이장천, 이정복한의병리학회 · 동의생리병리학회지2012 · 제26권 제2호대분청음(大分淸飮)추출물의 항염증 및 항산화 효과김용민, 김이화, 박세근, 원혜련대한미용학회 · 대한미용학회지2019 · 제15권 제4호

이 간행물의 다른 논문 (23건)

한의학의 체질식품에 대한 문헌적 고찰권강범, 류도곤, 한종현, 이봉희pp. 1207-1220맥진기를 이용한 새로운 부침맥 판단 방법이유정, 김재욱, 김근호, 김종열, 김성훈pp. 1221-1225감모변증도구 개발에 관한 예비 연구변준섭, 강위창, 양수영, 박양춘pp. 1226-1233사상체질 진단검사를 위한 데이터마이닝 알고리즘 연구황민우, 권영규, 박소정, 채한, 홍진우, 김영인, 엄일규, 김병철, 신상우, 김병주pp. 1234-1240『黃帝內經』중 五味에 대한 고찰안민섭, 이시형, 금경수, 박민철, 조은희, 김훈영, 문영옥, 박진수pp. 1247-1260
원문 보기